|Videos|March 22, 2022
PharmExec CEO Roundtable: Post-COVID Improvements
In this segment, leaders suggest areas to continue building on lessons learned during COVID, including the pharma industry as a tech destination and impact on patient outcomes.
Advertisement
Please read the
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
5